[ad_1]
AstraZeneca Inc said on Friday that the United States had approved the use of its drug Bydureon for patients as young as 10 years old to lower their blood sugar levels, as well as diet and exercise.
This medicine is given by injection once a week to patients with type 2 diabetes aged 10 to 18 years.
Type 2 diabetes is the most common disease in which the body does not make enough of the hormone insulin, which controls blood sugar levels.
Follow the health declaration via Google News
Source link
